Targeting inflammation in cancer-related-fatigue: a rationale for mistletoe therapy as supportive care in colorectal cancer patients.

ABSTRACT:

Background

Cancer-related fatigue (CRF) affects a majority of patients (pts) with symptoms lasting up to several years after finishing therapy. These symptoms lead to decreased health related quality of life. Fatigue during treatment for colorectal cancer is common, but poorly understood and can affect compliance with post-surgical cancer therapy. We examined the fatigue levels during first-line chemo- or radio-chemotherapy protocols, which were supported by a pharmaceutical mistletoe preparation (Iscador(®)Qu) (181patients). We compared the outcome to a parallel control group (143 patients), which did not receive this supportive care treatment.

Methods

The medical records of 324 patients with non-metastasized colorectal cancer (UICC stage I-III), which were obtained from ho

SUBMITTER: Bock PR 

PROVIDER: S-EPMC4133960 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature